8/120
0.3 / 5 stars
All 120 Win/Lose results shown below
NXTC Roast Me summary
NextCure, Inc. (NXTC). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseNXTC / S&P -85.02% / 15.20% |
LoseNXTC / S&P NXTC unavailable / 15.00% |
LoseNXTC / S&P NXTC unavailable / 50.40% |
| 2026-Q10/3 |
LoseNXTC / S&P -24.74% / -4.33% |
LoseNXTC / S&P NXTC unavailable / 11.30% |
LoseNXTC / S&P NXTC unavailable / 27.70% |
| 2025-Q41/3 |
WinNXTC / S&P 142.15% / 2.65% |
LoseNXTC / S&P NXTC unavailable / 9.00% |
LoseNXTC / S&P NXTC unavailable / 13.40% |
| 2025-Q30/3 |
LoseNXTC / S&P 6.16% / 8.12% |
LoseNXTC / S&P NXTC unavailable / 4.61% |
LoseNXTC / S&P NXTC unavailable / 13.45% |
| 2025-Q20/3 |
LoseNXTC / S&P -4.17% / 10.94% |
LoseNXTC / S&P NXTC unavailable / 4.83% |
LoseNXTC / S&P NXTC unavailable / 10.63% |
| 2025-Q10/3 |
LoseNXTC / S&P -37.74% / -4.27% |
LoseNXTC / S&P NXTC unavailable / 4.98% |
LoseNXTC / S&P NXTC unavailable / 10.57% |
| 2024-Q40/3 |
LoseNXTC / S&P -43.72% / 2.41% |
LoseNXTC / S&P NXTC unavailable / 5.25% |
LoseNXTC / S&P NXTC unavailable / 6.15% |
| 2024-Q30/3 |
LoseNXTC / S&P -13.84% / 5.89% |
LoseNXTC / S&P NXTC unavailable / 5.89% |
LoseNXTC / S&P NXTC unavailable / 6.11% |
| 2024-Q20/3 |
LoseNXTC / S&P -28.70% / 4.28% |
LoseNXTC / S&P NXTC unavailable / 5.38% |
LoseNXTC / S&P NXTC unavailable / 5.12% |
| 2024-Q11/3 |
WinNXTC / S&P 95.61% / 10.56% |
LoseNXTC / S&P NXTC unavailable / 5.71% |
LoseNXTC / S&P NXTC unavailable / 5.59% |
| 2023-Q40/3 |
LoseNXTC / S&P -11.63% / 11.69% |
LoseNXTC / S&P NXTC unavailable / 6.81% |
LoseNXTC / S&P NXTC unavailable / 7.78% |
| 2023-Q30/3 |
LoseNXTC / S&P -28.33% / -3.27% |
LoseNXTC / S&P NXTC unavailable / 7.52% |
LoseNXTC / S&P NXTC unavailable / -5.03% |
| 2023-Q21/3 |
WinNXTC / S&P 21.62% / 8.74% |
LoseNXTC / S&P NXTC unavailable / 9.50% |
LoseNXTC / S&P NXTC unavailable / -8.57% |
| 2023-Q10/3 |
LoseNXTC / S&P 4.96% / 7.50% |
LoseNXTC / S&P NXTC unavailable / 10.77% |
LoseNXTC / S&P NXTC unavailable / -15.69% |
| 2022-Q40/3 |
LoseNXTC / S&P -48.73% / 7.56% |
LoseNXTC / S&P NXTC unavailable / 11.88% |
LoseNXTC / S&P NXTC unavailable / -17.99% |
| 2022-Q30/3 |
LoseNXTC / S&P -41.49% / -4.88% |
LoseNXTC / S&P NXTC unavailable / 13.47% |
LoseNXTC / S&P NXTC unavailable / -1.41% |
| 2022-Q21/3 |
WinNXTC / S&P -3.29% / -16.10% |
LoseNXTC / S&P NXTC unavailable / 13.71% |
LoseNXTC / S&P NXTC unavailable / 11.04% |
| 2022-Q10/3 |
LoseNXTC / S&P -19.00% / -4.60% |
LoseNXTC / S&P NXTC unavailable / 15.97% |
LoseNXTC / S&P NXTC unavailable / 42.23% |
| 2021-Q40/3 |
LoseNXTC / S&P -10.98% / 11.03% |
LoseNXTC / S&P NXTC unavailable / 15.00% |
LoseNXTC / S&P NXTC unavailable / 96.40% |
| 2021-Q30/3 |
LoseNXTC / S&P -16.06% / 0.58% |
LoseNXTC / S&P NXTC unavailable / 10.77% |
LoseNXTC / S&P NXTC unavailable / 69.42% |
| 2021-Q20/3 |
LoseNXTC / S&P -19.78% / 8.55% |
LoseNXTC / S&P NXTC unavailable / 6.58% |
LoseNXTC / S&P NXTC unavailable / 51.81% |
| 2021-Q10/3 |
LoseNXTC / S&P -8.17% / 6.17% |
LoseNXTC / S&P NXTC unavailable / -1.06% |
LoseNXTC / S&P NXTC unavailable / 7.39% |
| 2020-Q42/3 |
WinNXTC / S&P 23.86% / 12.15% |
WinNXTC / S&P 252.58% / -3.72% |
LoseNXTC / S&P NXTC unavailable / -33.42% |
| 2020-Q30/3 |
LoseNXTC / S&P -58.96% / 8.93% |
LoseNXTC / S&P NXTC unavailable / -2.04% |
LoseNXTC / S&P NXTC unavailable / -27.10% |
| 2020-Q20/3 |
LoseNXTC / S&P -42.16% / 20.54% |
LoseNXTC / S&P NXTC unavailable / -0.46% |
LoseNXTC / S&P NXTC unavailable / -27.11% |
| 2020-Q10/3 |
LoseNXTC / S&P -34.19% / -19.60% |
LoseNXTC / S&P NXTC unavailable / 3.47% |
LoseNXTC / S&P NXTC unavailable / -14.75% |
| 2019-Q41/3 |
WinNXTC / S&P 82.59% / 9.07% |
LoseNXTC / S&P NXTC unavailable / 5.36% |
LoseNXTC / S&P NXTC unavailable / 2.99% |
| 2019-Q31/3 |
WinNXTC / S&P 105.94% / 1.70% |
LoseNXTC / S&P NXTC unavailable / 5.02% |
LoseNXTC / S&P NXTC unavailable / 0.21% |
| 2019-Q20/3 |
LoseNXTC / S&P NXTC unavailable / 4.30% |
LoseNXTC / S&P NXTC unavailable / 6.64% |
LoseNXTC / S&P NXTC unavailable / 8.65% |
| 2019-Q10/3 |
LoseNXTC / S&P NXTC unavailable / 13.65% |
LoseNXTC / S&P NXTC unavailable / 8.12% |
LoseNXTC / S&P NXTC unavailable / 14.29% |
| 2018-Q40/3 |
LoseNXTC / S&P NXTC unavailable / -13.52% |
LoseNXTC / S&P NXTC unavailable / 9.05% |
LoseNXTC / S&P NXTC unavailable / 18.23% |
| 2018-Q30/3 |
LoseNXTC / S&P NXTC unavailable / 7.71% |
LoseNXTC / S&P NXTC unavailable / 10.21% |
LoseNXTC / S&P NXTC unavailable / 19.06% |
| 2018-Q20/3 |
LoseNXTC / S&P NXTC unavailable / 3.43% |
LoseNXTC / S&P NXTC unavailable / 9.03% |
LoseNXTC / S&P NXTC unavailable / 14.46% |
| 2018-Q10/3 |
LoseNXTC / S&P NXTC unavailable / -0.76% |
LoseNXTC / S&P NXTC unavailable / 7.68% |
LoseNXTC / S&P NXTC unavailable / 12.46% |
| 2017-Q40/3 |
LoseNXTC / S&P NXTC unavailable / 6.64% |
LoseNXTC / S&P NXTC unavailable / 7.03% |
LoseNXTC / S&P NXTC unavailable / 13.82% |
| 2017-Q30/3 |
LoseNXTC / S&P NXTC unavailable / 4.48% |
LoseNXTC / S&P NXTC unavailable / 5.68% |
LoseNXTC / S&P NXTC unavailable / 17.57% |
| 2017-Q20/3 |
LoseNXTC / S&P NXTC unavailable / 3.09% |
LoseNXTC / S&P NXTC unavailable / 4.83% |
LoseNXTC / S&P NXTC unavailable / 17.74% |
| 2017-Q10/3 |
LoseNXTC / S&P NXTC unavailable / 6.07% |
LoseNXTC / S&P NXTC unavailable / 3.67% |
LoseNXTC / S&P NXTC unavailable / 13.32% |
| 2016-Q40/3 |
LoseNXTC / S&P NXTC unavailable / 3.82% |
LoseNXTC / S&P NXTC unavailable / 2.09% |
LoseNXTC / S&P NXTC unavailable / 7.05% |
| 2016-Q30/3 |
LoseNXTC / S&P NXTC unavailable / 3.85% |
LoseNXTC / S&P NXTC unavailable / 0.20% |
LoseNXTC / S&P NXTC unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | NXTC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 22.27% | 20.78% |
| Annualized return | 22.27% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | NXTC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -93.16% | 83.14% |
| Annualized return | -41.52% | 12.86% |
10Y · 2019-05-09 to 2026-08-28
| Metric | NXTC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.42% | 319.30% |
| Annualized return | -30.64% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |